| AChE | Acetylcholinesterase |
| Ac-CoA | Acetyl-Coenzyme A |
| ACh | Acetylcholine |
| AD | Alzheimer’s Disease |
| APP | Amyloid Precursor Protein |
| Aβ | Amyloid-β-peptide |
| BACE-1 | Beta-secretase 1 |
| BBB | Blood Brain Barrier |
| BuChE | Butyrylcholinesterase |
| CNS | Central Nervous System |
| ChEs | Cholinesterases |
| CAS | Catalytic Active Site |
| ChAT | choline acetyltransferase |
| DPPH | 2,2-diphenyl-1-picrylhydrazyl |
| EGFR | epidermal growth factor receptor |
| FDA | Food and Drug Administration |
| GSK-3β | Glycogen Synthase Kinase 3 beta |
| GPX-like | glutathione peroxidase-like |
| hAChE | human acetylcholinesterase |
| hBuChE | human butyrylcholinesterase |
| HER2 | human epidermal growth factor receptor 2 |
| MTDLs | Multitarget Directed Ligands |
| MAO-B | Monoamine oxidase B |
| MD | Molecular Dynamics |
| MVD | MolegroVirtual Docker |
| NADPH | Nicotinamide Adenine Dinucleotide Phosphate |
| NMDAR | N-methyl-D-aspartate receptor |
| PDE4D | Phosphodiesterase 4D |
| PAS | Peripheral Anionic Site |
| PDE9A | Phosphodiesterase 9A |
| PROTAC | Proteolysis Targeting Chimera |
| ROS | Reactive Oxygen Species |
| SGLT1 | sodium glucose co-transporter-1 |
| SGLT2 | sodium glucose co-transporter-2 |
| UV | Ultraviolet |
| WHO | World Health Organization |
| XO | Xanthine Oxidase |